SENSATEX - Key Persons
Job Titles:
- Vice President of Business Development
Ari Reubin brings 15 years of experience in strategic marketing, alliances, capital markets, product management, operations, and engineering within the semiconductor, telecommunications, and notebook computer industries. He spent over 10 years at Texas Instruments, where he served as Director of the worldwide Digital Image Sensor Products group, Director of Strategic Alliances for the Notebook Computer group, Manager of Technology Transfer for TI at the Sematech consortium, and in key engineering positions. Mr. Reubin has also served as an Adjunct Professor at the University of Texas at Dallas Business School. In 1998, he co-founded Darwin‚ s Beagle, a venture consulting firm. He holds a BS in Materials Engineering and Marketing Management from Michigan State University and an MS in Polymer Engineeringfrom the University of Illinois at Urbana-Champaign.
Job Titles:
- Member of the Board of Directors
- Member of the National Academy of Sciences
Dr. Young has an extensive background in immunology, regulatory and defense-related affairs. He currently serves on the Board of Directors for EluSys Therapeutics. Dr. Young was formerly Commissioner of the FDA. Dr. Young's other public service work includes
positions as a Rear Admiral at the U.S. Public Health Service and a senior advisor to DARPA. Dr. Young is also a member of the National Academy of Sciences. Dr. Young received his BA from Union College, his M.D. from the University of the State of New York and his Ph.D. from Western Reserve University.
Job Titles:
- Member of the Board of Directors
Dr. Himawan has extensive experience in guiding and managing the research and development of scientific enterprises with commercial objectives. Prior to Sensatex, Dr. Himawan co-founded and served as Chief Scientific Officer at EluSys Therapeutics, a venture-backed biotechnology company. Prior to EluSys, Dr. Himawan was Managing Director at Athena Ventures, LLC. Before his time at Athena, Dr. Himawan was employed at Genzyme Corporation, a biotechnology company located in Cambridge, Massachusetts. He is a member of the New York Academy of Sciences, Sigma Xi (The Scientific Research Society), the American Society for Microbiology, and the American Association for the Advancement of Science. Dr. Himawan holds a Ph.D. degree from the Department of Biological Chemistry and Molecular Pharmacology at Harvard University and a BS in Life Sciences from the Massachusetts Institute of Technology.
Mr. Wolf has substantial experience in creating, financing, nurturing and growing new ventures based upon breakthrough research and technology. Mr. Wolf was previously the Managing General Partner of Seed-One Ventures, LLC, a New York based venture capital firm, where he founded and served as CEO and Chairman of several start-up companies including EluSys Therapeutics, Inc., a venture-backed biotechnology company. Mr. Wolf received his MBA from Stanford Business School, his JD from New York University School of Law and his BA from the University of Chicago.
Job Titles:
- Professor of Biomedical Engineering at the University of Wisconsin - Madison
Dr. Webster is a Professor of Biomedical Engineering at the University of Wisconsin-Madison. His professional research areas include medical instrumentation and sensors, electrode design, sensors for vigilance and alertness, measuring ventilation and apnea, monitoring and stimulating electrodes, biopotential amplifiers and interference, design of cardiac pacemakers and defribrillators, and the design of pulse oximeters. Dr. Webster has consulted for a large number of medical device manufacturers, including 3M, General Electric, and Healthdyne. He is editor of the most-used text in biomedical engineering, Medical Instrumentation: Application and Design, Third Edition, and has developed 18 other books, including the Encyclopedia of Medical Devices and Instrumentation. Dr. Webster is a Fellow of the Institute of Electrical and Electronics Engineers, Instrument Society of America, American Institute of Medical and Biological Engineering, and Institute of Physics. He is the recipient of the AAMI Foundation Laufman-Greatbatch Prize and the ASEE/Biomedical Engineering Division, Theo C. Pilkington Outstanding Educator Award. He has also been a member of the IEEE-EMBS Administrative Committee and the NIH Surgery and Bioengineering Study Section. He received his BEE from Cornell University and his MSEE and Ph.D. from the University of Rochester.
Mr. Weisshaar has 26 years of experience in the executive and managerial leadership of global technology-based businesses. Prior to joining Sensatex, he served as Chief Financial Officer of Becton Dickinson, a $3.4 billion global medical devices and biosciences corporation. During his 11-year term there, he also served as President of the Worldwide Consumer Healthcare business, President of the Bioscience Cell Analysis Sector, President of the global medical supplies business, and Vice President of Corporate Planning and Development. Prior to Becton Dickinson, Mr. Weisshaar was a Senior Engagement Manager at McKinsey & Company, where he consulted with top management of healthcare and manufacturing industries on issues of business strategy, operations, marketing and product development. Prior to McKinsey, he served in various managerial roles at Raychem Corporation, a high technology manufacturer of the electronics, telecom, and energy industries. Mr. Weisshaar received his BS in Chemical Engineering from the Massachusetts Institute of Technology and his MBA from Harvard Business School.
Lynn Whittington brings more than 30 years of experience in information sciences, computer architecture and development of wireless communications systems to his role as Chief Technology Officer of Sensatex, Inc. In this position, he will focus on defining, designing and integrating the technology requirements for a highly reliable system of real-time acquisition, processing, transmission, management and presentation of critical data. Prior to Sensatex, Mr. Whittington spent more than 20 years with Motorola, most recently as the Chief Technologist for the company's next generation wireless network, Aspira, where he co-led the 275-person Network Architecture & Technology organization. During that time, he was heavily involved in the convergence of wireless and Internet technologies, addressing issues of high system reliability between those environments. Before joining Motorola, he spent 10 years as a systems engineer with Unitech in Austin, TX, where he focused on communications, graphics and mass storage technologies. Mr. Whittington holds five patents from the U.S. Patent office in the area of communications, semiconductors and computers, and is the author of numerous papers and presentations at major industry conferences such as SuperComm and the International Engineering Consortium. He received a BSEE in Information Science and MSEE in Computer Architecture from the University of Texas at Austin.
Dr. New is Chairman of the Department of Pediatrics, Pediatrician-in-Chief and Harold and Percy Uris Professor of Pediatric Endocrinology at the New York Hospital-Cornell Medical Center. Dr. New's research is focused on the areas of pediatric endocrinology, where she is known for her pioneering research and clinical work on congenital adrenal hyperplasia. Dr. New and has received many honors and awards including the Basic Science Award from the Society for the Advancement of Women's Health Research and the British Endocrine Society for Endocrinology Dale Medal. Dr. New is also a member of numerous professional and medical organizations and was recently appointed to the National Advisory Research Resources Council of the National Institutes of Health. She has served as a member of the Food and Drug Administration's Endocrine and Metabolic Drug Advisory Committee since 1994 and was recently elected to the National Academy of Sciences. Dr. New received her BA at Cornell University and her M.D. from the University of Pennsylvania.
Job Titles:
- Member of the Scientific Advisory Board
Dr. Fink is currently the Watson Professor of Surgery, Anesthesiology, and Critical Care Medicine, as well as Chief of the Division of Critical Care Medicine at the University of Pittsburgh Medical School and the University of Pittsburgh Medical Center. Prior to this, he was on the faculty of Harvard Medical School, during which time he was named Johnson & Johnson Professor of Surgery and Surgeon-in-Chief at the Beth Israel Hospital. In 1986, while serving on the faculty at the University of Massachusetts Medical Center in Worcester as a general/trauma surgeon and Director of the Surgical Intensive Care Unit (SICU), Dr. Fink received his first grant from the NIH for research into the pathophysiology of sepsis and septic shock. This topic has remained the focus of his research interests for the past twenty years and he has been continuously funded by the NIH ever since. Dr. Fink has won numerous awards for teaching and was honored by the Society of Critical Care Medicine with the Laerdal Award and as a Millennium Speaker. He has edited or co-edited eight books, all dealing with various aspects of critical care medicine. Dr. Fink obtained his M.D. degree, graduating cum laude, from Washington University School of Medicine in St. Louis and completed his residency in General Surgery at the National Naval Medical Center in Bethesda.
Job Titles:
- Vice President of Medical Affairs
Dr. Belsky has expertise in the clinical practice of internal medicine and cardiovascular diseases. Prior to his training in cardiology, Dr. Belsky was on the clinical academic faculty at Cornell Medical College and was a member of the Cornell Medical Practice. He is a fellow of the American College of Cardiology, the American College of Chest Physicians, a member of the American College of Physicians and a Clinical Assistant Professor of Medicine at New York University School of Medicine. He was formerly a Vice President at Athena Ventures, LLC. Dr. Belsky received his M.D. from the University of California at San Francisco, and his A.B. in Biology from Brown University, where he was elected Phi Beta Kappa.
Job Titles:
- Professor of Pediatric Endocrinology at the New York Hospital - Cornell Medical Center
Job Titles:
- Member of the Board of Directors
- Founding Investor in Sensatex Inc
Richard (David) Palmer, a founding investor in Sensatex Inc., has been a first-round investor in several successful health-care related start-ups. From 1972 until 1993, he founded several privately-held real estate development companies and other service businesses. Dr. Palmer is currently president of Palm Florida Management, a group that manages various real estate and investment assets. For over 20 years, he taught Management Ethics at SUNY College at Fredonia, New York. He received his BA and MA from Oberlin College and his Ph.D. in Philosophy from Ohio State University.
Job Titles:
- Member of the Board of Directors
- Chairman of the Board of Directors of St. Jude Medical, Inc
Ronald Matricaria currently serves as Chairman of the board of directors of St. Jude Medical, Inc., the undisputed global leader of heart valve products and a major supplier of cardiac rhythm management products and services. Until 1999, he also served as President and CEO of St. Jude. In his six years with the Company, Mr. Matricaria led its diversification from one to three technology platforms, and oversaw a revenue increase from $225MM to over $1.1 billion and an employee base expansion from 700 to 5,000. Prior to St. Jude Medical, Mr. Matricaria spent 23 years with Eli Lilly and Company, Inc., where he held various executive-level positions such as EVP of the Pharmaceutical Division, President of North American operations, and President of Eli Lilly International Corporation. Mr. Matricaria received his BS degree from the Massachusetts College of Pharmacy and was also awarded an honorary Doctor of Science degree in pharmacy in recognition of his contributions to the practice of pharmacy.
Job Titles:
- Member of the Board of Directors
Mr. Gelbman is a former member of the Executive Committee of Johnson & Johnson. In 1998, he was named Worldwide Chairman of the Health Systems and Diagnostics Group, becoming responsible for Johnson & Johnson businesses such as Healthcare Systems, Lifescan, Ortho-Clinical Diagnostics, and Therakos. In addition, Mr. Gelbman was responsible for guiding Johnson & Johnson's annual strategic planning process and led the Reengineering Task Force. Previous to this, Mr. Gelbman served as Worldwide Chairman of Johnson & Johnson's Pharmaceuticals and Diagnostics Group, a position to
which he was appointed in 1994. In his 27 years at Johnson & Johnson, Mr. Gelbman also served as the Group Chairman of Janssen GmbH, the Vice President of Johnson & Johnson International, and various other managerial positions. He received his BA from Rollins College and his MBA from the Crummer School of Business.
Job Titles:
- Vice President of Development
Steve Scott brings almost 20 years of experience in software development, hardware development, computer architecture and development of wireless communications systems to Sensatex. In this position, he will focus on architecting, developing, and delivering a highly reliable system for real-time acquisition, processing, transmission, management and presentation of critical data. Prior to Sensatex, Mr. Scott spent more than 18 years with Motorola, most recently as a major software architect for the company's next generation wireless network, Aspira. During that time, he was a major contributor in the convergence of wireless and Internet technologies, focusing on the development of highly extensible and reliable wireless access-independent core networks. Mr. Scott received a BSEE from Wichita State University and an MSEE from the University of Texas at Arlington.
Job Titles:
- Chairman of the Scientific Advisory Board
Dr. Jayaraman is the primary developer of the Smart Shirt Wearable Motherboard!". He currently serves as a Professor of Textile Engineering at the Georgia Institute of Technology, where he has been since 1985. Dr. Jayaraman received the 1989 Presidential Young Investigator Award from the National Science Foundation for his research in the area of computer aided manufacturing and enterprise architecture. In 1994, he was elected a fellow of the Textile Institute (UK) and in 1997, received the Georgia Outstanding Manufacturing Researcher of the Year Award from Georgians for Manufacturing. Dr. Jayaraman's publications include a 1991 textbook on computer-aided problem solving published by McGraw-Hill. He is also Technical Editor of Information Technology for America's Textiles International, a leading textile trade publication, as well as an Editor for the Journal of the Textile Institute, UK. He received his Ph.D. from North Carolina State University and his Masters and Bachelors of Technology degrees from the University of Madras in India.